Carboprost trometamol in the management of the third stage of labor

Int J Gynaecol Obstet. 1993 Sep;42(3):247-50. doi: 10.1016/0020-7292(93)90219-m.

Abstract

Objective: To compare carboprost trometamol with methylergometrine in managing the third stage of labor.

Method: One hundred and fifty parturient women were randomly assigned to use carboprost trometamol or methylergometrine immediately after delivery.

Result: Both the duration of the third stage and the mean blood loss were significantly less in the carboprost group than the methergine group (P < 0.001).

Conclusion: Carboprost trometamol is a more potent uterotonic drug than methylergometrine. Reducing blood loss in parturient women is very important especially in cases where there is the likelihood of anemia.

Publication types

  • Clinical Trial
  • Comparative Study
  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Carboprost / administration & dosage*
  • Carboprost / adverse effects
  • Drug Combinations
  • Female
  • Humans
  • Labor Stage, Third / drug effects*
  • Methylergonovine / administration & dosage
  • Methylergonovine / adverse effects
  • Postpartum Hemorrhage / prevention & control
  • Pregnancy
  • Tromethamine / administration & dosage*
  • Tromethamine / adverse effects
  • Uterine Contraction / drug effects

Substances

  • Drug Combinations
  • Tromethamine
  • Carboprost
  • carboprost tromethamine
  • Methylergonovine